366
Participants
Start Date
April 30, 2007
Primary Completion Date
May 31, 2009
Study Completion Date
May 31, 2009
Lansoprazole
Lansoprazole 15 mg, capsules, orally, once daily and gefarnate placebo-matching capsules, orally, twice daily for up to 6 to 24 months.
Gefarnate
Gefarnate 50 mg, capsules, orally, twice daily and lansoprazole placebo-matching capsules, orally, once daily for up to 6 to 24 months.
Kasugai-shi
Yotsukaido-shi
Matsuyama
Fukui-shi
Chikushi-gun
Fukuoka
Kurume-shi
Munakata-shi
Onga-gun
Gifu
Maebashi
Higashihiroshima-shi
Kure-shi
Asahikawa-shi
Chitose-shi
Sapporo
Kato-shi
Nishinomiya-shi
Hitachi-Naka
Yuki-shi
Hakusan-shi
Komatsu-shi
Takamatsu
Kagoshima
Kamakura-shi
Kawasaki-shi
Sagamihara-shi
Yamato-shi
Yokohama
Kochi
Susaki-shi
Kumamoto
Kyoto
Ise-shi
Shima-shi
Yokkaichi-shi
Sendai
Ebino-shi
Miyazaki
Miyazaki-gun
Matsumoto-shi
Omura-shi
Niigata
Beppu-shi
Okayama
Daito-shi
Osaka
Sakai-shi
Ogi-shi
Saga
Hanyu-shi
Sunto-gun
Shimotsuke-shi
Naruto-shi
Tokushima
Chuo-ku
Hachioji-shi
Kiyose-shi
Machida-shi
Meguro-ku
Nishi-Tokyo-shi
Shibuya-ku
Shinjuku-ku
Toshima-ku
Tottori-shi
Yonago-shi
Shimonoseki-shi
Yanai-shi
Lead Sponsor
Takeda
INDUSTRY